The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in patients who are in the early stages of the disease. The Medicines and ...

Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS. The National ...